Accessibility Menu
 
Acro Biomedical logo

Acro Biomedical

(OTC) ACBM

Current Price$0.03
Market Cap$1.56M
Since IPO (2018)-99%
5 Year-99%
1 Year+3,614%
1 Month+0%

Acro Biomedical Financials at a Glance

Market Cap

$1.56M

Revenue (TTM)

$0.00

Net Income (TTM)

$134.62K

EPS (TTM)

$-0.00

P/E Ratio

-11.82

Dividend

$0.00

Beta (Volatility)

-2.50 (Low)

Price

$0.03

Volume

155

Open

$0.03

Previous Close

$0.03

Daily Range

$0.03 - $0.03

52-Week Range

$0.00 - $0.10

ACBM News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Acro Biomedical

Industry

Healthcare Providers and Services

Employees

1

CEO

Yu-Ting Su

Headquarters

Fishers, IN 46038, US

ACBM Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

0%

Return on Capital

48%

Return on Assets

-35%

Earnings Yield

-8.46%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.56M

Shares Outstanding

60.04M

Volume

155

Avg. Volume

61.281

Financials (TTM)

Gross Profit

$0.00

Operating Income

$154.02K

EBITDA

$154.02K

Operating Cash Flow

$196.30K

Capital Expenditure

$0.00

Free Cash Flow

$196.30K

Cash & ST Invst.

$4.10K

Total Debt

$325.51K

Acro Biomedical Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$1.56M

N/A

Market Cap/Employee

$1.56M

N/A

Employees

1

N/A

Net Income

$43.77K

-324.9%

EBITDA

$60.27K

-574.6%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Net Cash

$3.87K

+102.3%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

-100.0%

Return on Assets

-34.76%

N/A

Return on Invested Capital

48.07%

N/A

Free Cash Flow

$49.82K

-121.1%

Operating Cash Flow

$49.82K

-121.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
NSPDFNaturally Splendid Enterprises Ltd.
$0.04+0.00%
MLPHMolecular Pharmacology (USA), Ltd.
$0.00+0.00%
BSSPBaseline Productions, Inc.
$0.00+0.00%
HDVYHealth Discovery Corporation
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$15.47+0.09%
FFord Motor Company
$14.93+0.09%
AALAmerican Airlines Group
$13.85+0.02%
NIONio
$5.20-0.07%

Questions About ACBM

What is the current price of Acro Biomedical?

Acro Biomedical is trading at $0.03 per share.

What is the 52-week range for Acro Biomedical?

Over the past 52 weeks, Acro Biomedical has traded between $0.00 and $0.10.

How much debt does Acro Biomedical have?

As of the most recent reporting period, Acro Biomedical reported total debt of $375,108.

How much cash does Acro Biomedical have on hand?

Acro Biomedical reported $3,873 in cash and cash equivalents in its most recent financial results.

What is Acro Biomedical’s dividend yield?

Acro Biomedical does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.